Exploratory Clinical Trial of Honghua Xiaoyao Pills for the Treatment of Liver Depression and Haemostasis‐Type Hyperplasia of Mammary Glands: A Single‐Centre, Single‐Arm Study
The Breast Journal · 2026-01 · 2026 (1)
DOI: 10.1155/tbj/3499662 ↗Kurz gefasst
Klinische Studie in der Zeitschrift The Breast Journal, online erschienen am 24.06.2026. Verfasst von Li Zheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences, Beijing, 100091, China, cacms.ac.cn. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Breast Diseases, Mammary Glands, Human, Liver Diseases. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Background
Hyperplasia of mammary glands (HMG) is a common benign disease of the female breast.
Objective
This study aimed to observe the clinical efficacy and safety of Honghua Xiaoyao pills in the treatment of liver depression and haemostasis‐type HMG, as well as their impact on menstruation.
Methods
Sixty patients diagnosed with liver depression and haemostasis‐type HMG in the breast disease department of our hospital were selected as the study participants. The treatment involved oral administration of Honghua Xiaoyao pills: four pills per dose, three times a day, for a duration of 3 months without interruption during menstruation. Hormones, Western painkillers and similar Chinese herbal medicines were prohibited during the trial. Changes in breast pain, breast masses, menstrual volume and safety indicators were observed.
Results
Three patients were lost to follow‐up after 2 months of treatment, and four patients voluntarily withdrew from the study. The changes in breast pain scores, breast mass size scores and breast mass texture scores relative to baseline and their respective change rates showed statistically significant differences ( p < 0.0001). Changes in lower abdominal distension, breast distension, menstrual blood clots, chest tightness/discomfort and emotional scores relative to baseline were also statistically significant ( p < 0.0001).
Conclusion
Honghua Xiaoyao pills are effective in reducing breast pain, shrinking breast masses and improving lower abdominal distension, breast distension, menstrual blood clots, chest tightness/discomfort and emotional symptoms in patients with liver depression and haemostasis‐type HMG. Trial Registration: International Traditional Medicine Clinical Trial Registry: ITMCTR2024000165
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences, Beijing, 100091, China, cacms.ac.cn.
- Jiangxi Puzheng Pharmaceutical Co, Ltd., Ji'an, Jiangxi, 343199, China.
ORCID-Profile: Li Zheng, Wei Liu, Jia-Ying Qiu, Yang Zhao, Xiao-Jun Zhang
Zitieren
APA
Zheng, L., Liu, W., Qiu, J. Y., Zhao, Y., Li, X. F., Zhou, Z. G., Wang, J. T., Cui, Y., & Zhang, X. J. (2026). Exploratory Clinical Trial of Honghua Xiaoyao Pills for the Treatment of Liver Depression and Haemostasis‐Type Hyperplasia of Mammary Glands: A Single‐Centre, Single‐Arm Study. The Breast Journal, 2026(1). https://doi.org/10.1155/tbj/3499662
Vancouver
Zheng L, Liu W, Qiu JY, Zhao Y, Li XF, Zhou ZG, et al. Exploratory Clinical Trial of Honghua Xiaoyao Pills for the Treatment of Liver Depression and Haemostasis‐Type Hyperplasia of Mammary Glands: A Single‐Centre, Single‐Arm Study. The Breast Journal. 2026;2026(1). doi:10.1155/tbj/3499662
BibTeX
@article{Zheng2026,
author = {Zheng, Li and Liu, Wei and Qiu, Jia-Ying and Zhao, Yang and Li, Xiao-Feng and Zhou, Zhi-Gang and Wang, Jiang-Tao and Cui, Yu and Zhang, Xiao-Jun},
title = {Exploratory Clinical Trial of Honghua Xiaoyao Pills for the Treatment of Liver Depression and Haemostasis‐Type Hyperplasia of Mammary Glands: A Single‐Centre, Single‐Arm Study},
journal = {The Breast Journal},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/tbj/3499662}
}
EUVIMED